⌘K

Home/Filings/4/0001209191-16-094238

4//SEC Filing

aTYR PHARMA INC 4

Accession 0001209191-16-094238

$ATYRCIK 0001339970operating

View on SEC.gov Company Profile

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 6:03 PM ET

Size

5.5 KB

Accession

0001209191-16-094238

Insider Transaction Report

Form 4

Period: 2016-01-27

aTYR PHARMA INCLIFE

Vice President, Finance

Transactions

Award
Employee Stock Option (right to buy)
2016-01-27+20,000→ 20,000 total
Exercise: $6.14Exp: 2026-01-27→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 1, 2016, such that this option will be fully exercisable on January 1, 2020. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

aTYR PHARMA INC

CIK 0001339970

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001339970

Filing Metadata

Form type: 4
Filed: Jan 28, 7:00 PM ET
Accepted: Jan 29, 6:03 PM ET
Size: 5.5 KB

View on SEC.gov